New Jersey Institute of Technology

Digital Commons @ NJIT
Theses

Electronic Theses and Dissertations

Spring 5-31-2004

Extrusion and evaluation of degradation rate and porosity of small
diameter collagen tubes
Bipinkumar G. Patel
New Jersey Institute of Technology

Follow this and additional works at: https://digitalcommons.njit.edu/theses
Part of the Biomedical Engineering and Bioengineering Commons

Recommended Citation
Patel, Bipinkumar G., "Extrusion and evaluation of degradation rate and porosity of small diameter
collagen tubes" (2004). Theses. 563.
https://digitalcommons.njit.edu/theses/563

This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Digital
Commons @ NJIT. It has been accepted for inclusion in Theses by an authorized administrator of Digital Commons
@ NJIT. For more information, please contact digitalcommons@njit.edu.

Copyright Warning & Restrictions
The copyright law of the United States (Title 17, United
States Code) governs the making of photocopies or other
reproductions of copyrighted material.
Under certain conditions specified in the law, libraries and
archives are authorized to furnish a photocopy or other
reproduction. One of these specified conditions is that the
photocopy or reproduction is not to be “used for any
purpose other than private study, scholarship, or research.”
If a, user makes a request for, or later uses, a photocopy or
reproduction for purposes in excess of “fair use” that user
may be liable for copyright infringement,
This institution reserves the right to refuse to accept a
copying order if, in its judgment, fulfillment of the order
would involve violation of copyright law.
Please Note: The author retains the copyright while the
New Jersey Institute of Technology reserves the right to
distribute this thesis or dissertation
Printing note: If you do not wish to print this page, then select
“Pages from: first page # to: last page #” on the print dialog screen

The Van Houten library has removed some of the
personal information and all signatures from the
approval page and biographical sketches of theses
and dissertations in order to protect the identity of
NJIT graduates and faculty.

ABSTRACT
EXTRUSION AND EVALUATION OF DEGRADATION RATE AND
POROSITY OF SMALL DIAMETER COLLAGEN TUBES
by
Bipinkumar G. Patel
The limited availability of autografts and failure of small diameter synthetic vascular
grafts has stimulated continuing efforts to develop small diameter vascular grafts based
on natural materials. The small diameter collagen tubes were extruded using bovine
collagen type I. The biodegradation rate was determined and compared for small
diameter collagen tubes crosslinked with glutaraldehyde and N-(3dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and Nhydroxysuccinimide (NHS) to evaluate physio-chemical properties. The samples were
also evaluated for their surface area and porosity using mercury porosimeter. The noncrosslinked tubes almost completely degraded after 2 hours. The tubes crosslinked with
EDC/NHS degraded slower than the ones crosslinked with glutaraldehyde. The
biodegradation rate seemed to be dependent on concentration of crosslinking agent and
collagen suspension. The in-vitro model equation for small diameter collagen tubes
showed linear behavior. The porosity characterization study showed that EDC/NHS
treated tubes are more porous and have more surface area than glutaraldehyde treated
tubes. Future work on this area will be to study biodegradation rate for small diameter
collagen tubes over longer period of time.
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CHAPTER 1
INTRODUCTION

The collagens are a family of highly characteristic fibrous proteins found in all
multicellular animals. It is a biodegradable, biocompatible, and non-nonimmunogenic
structural protein, which makes it a suitable compound for a variety of biomedical
applications. This family of proteins accounts for 25% or more of total body protein and
provides an important structural framework for most body structures, including skeleton,
skin and blood vessels. The word collagen is derived from kolla the Greek word for glue.
It is present in high amounts in the ECM of numerous tissues. Collagen is regarded as
one of the most useful biomaterials. It has found ample usage in the biomedical field due
to its low antigenicity, its biodegradability and its good mechanical, haemostatic and cellbinding properties [1, 2].

1.1 Collagen Overview

Collagen is a fibrous protein and constitutes the major protein component of skin, bone,
tendon, ligament, cartilage, basement membrane and other forms of connective tissue. It
is the most abundant protein in the animal kingdom. Collagen fibers function in
biological structures to maintain tissue shape, transmit and absorb loads, prevent
premature mechanical failure, partition cells and tissues into functional units, and act as a
scaffold that supports tissue architecture [8]. In bone, for example, collagen fibers
reinforce the calcium phosphate mineral base. Despite its great strength, bone retains
flexibility because of its collagen content.

1
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Collagen has been used extensively in medicine and in surgery. Collagen based
devices have been used, as noted above, as nerve regeneration tubes, as sutures,
haemostatic fiber and sponges, wound dressings, neurosurgical sponges, injectable
implants for soft tissue augmentation, pharmaceutical carriers, ophthalmic aqueousvenous shunts, contact lenses and the like.
The properties of collagen which favor its use as a biomaterial are many. It has a
high order of tensile strength and low extensibility. Collagen is biodegradable, and when
implanted in the body, is absorbed at a rate that can be controlled by the degree of intra or
intermolecular cross-linking imparted to the collagen molecule by chemical or physical
treatment. Collagen products can thus be designed such that, on implantation, they will be
completely absorbed in a few days or in months. The collagen can also be chemically
treated so that it becomes non-absorbable while still retaining its hydrophilic character
and its good tissue response. Although native collagen is a very weak antigen, it can be
made, for all practical purposes, immunologically inert by means well known to those
skilled in the art.
The main sources of collagen for commercial applications are bovine tendons,
calf, steer or pig hide. Generally, reconstituted collagen products are prepared by
purification of native collagen by enzyme treatment and chemical extraction. The purified
collagen is then dispersed or dissolved in solution, filtered and retained as such, or is
reconstituted into fiber, film or sponge by extrusion, casting or lyophilization techniques.
Although the collagen of skin, tendons, bone, cartilage, blood vessels and basement
membrane are similar in structure and composition, they do differ slightly in relative
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amino acid content, amino acid sequence and in architecture. The collagen of native skin,
tendons, ligaments and bone are primarily Type I collagen [5].
Collagen appears as bundles of individual, nonbranching fibrils, varying greatly in
diameter from tissue to tissue. In skin, under an ordinary light microscope, these bundles
appear to be woven together at random, but a definite order emerges if larger areas of
tissue are examined. In tendon, collagen fibers are arranged in long parallel bundles. In
the cornea of the eye, transparency depends upon the orderly arrangement of collagen
fibers that probably have a refractive index identical to that of the substance in which
they are embedded. In bone, the collagen fibrils are organized much like the struts and
girders of a bridge. In cartilage, which coats the inner surface of joints and which must
have considerable elasticity and smoothness, the collagen fibers are usually very thin,
randomly oriented and embedded in a large volume of extracellular matrix [6].
In skin and basement membrane, it occurs as a reinforced fiber. It can also
function as the winding of a pressure vessel, as in nematodes, earthworms and sharks. In
tendon and muscle, it is concerned with transmitting tensile stresses and it is in this form,
notably rat tail tendon, that it has been most studied. Just as with keratins, the basic
microfibril (in this instance, tropocollagen) is assembled into larger and larger units
giving a hierarchy of structure which can finally form such components as tendon (Figure
1.1) [7].
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Figure 1.1 Hierarchy of Collagen Structure.

1.2 Structure of Collagen
The common structural feature found in all collagens is a triple helix that consists of three
left-handed helixes that are wound into a right-handed triple helix. Individual a-chains,
which are the basic units of collagen, contain one or more polypeptide sequences (
Gly-XY,wherandposit frequnlycpidboeanhyrxpli)t
form the triple helix with one or more nontriple helical modules (Figure 1.2a). The achains vary in size from 600 to 3,000 amino acids [4].

Figure 1.2a Collagen Triple Helix.
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First, the amino acid composition of the collagen a-chain will be discussed. Glycine
constitutes about one-third of the residues, proline about 13%, and hydroxyproline about
10%. Because only small quantities of hydroxyproline are present in other proteins,
assays for hydroxyproline are frequently used to determine collagen content [2]. The ccchains have been classified into fibrillar, nonfibrillar, and novel collagens. The fibrillar
collagens include types I, II, III, V, and XI, which form cross-striated fibrils, and all share
a triple helical region containing about 1,000 amino acids per chain, which has a length
of about 300 nm (Figure 1.2b). Nonfibrillar collagens may associate with fibrillar
collagens or form separate networks of microfibrils. These collagens contain triple helical

Figure 1.2b Diagram of Procollagen Molecule.
segments of varying lengths interrupted by sequences containing larger segments of
noncollagenous sequences. The noncollagenous sequences include modules containing
sequences found in von Willebrand factor (binds to and protects factor VIII, which is
necessary for blood coagulation), collagen type IV, and fibronectin. The novel collagens
are similar to the nonfibril-forming collagens because they consist of triple helical
regions separated by nontriple helical regions [4].
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The different a-chains are bonded to each other in the following way:
1) By H-bridges. NH... from the glycines and CO... from residues of the other
chain. These H...0 bonds are perpendicular on the axis of the collagen chains.
2) By H-bridges of hydroxyl-groups of hydroxyprolines.
3) By H-bridges with water molecules.
All these bonds stabilize the triple-helical structure of collagen. However, the
repulsion of the prolines already gives the helical structure and turns the H-side chain of
the glycines to the inside of the helix. This happens without the help of H- bridges. Inside
the triple helix there would be no more space than for the small H- side chains of
glycines. All the bulky side chains have to point to the outside of the triple helix of the
collagen. In summary: glycines, prolines and hydroxyprolines are mainly responsible for
the triple helix structure. The remaining amino acid residues are expected to be
responsible for higher order structural regularities.
Two special amino acids occur in collagen almost exclusively:
1) 4- and 3-hydroxyproline,
2) 5-hydroxylysine
The amino acid residues hydroxyproline and hydroxylysine exhibit special
functions for the collagen structure. The 4- and 3-hydroxyprolines are important for
interchain linking with H-bridges to stabilize the helical structure. The stability of the
collagen helix depends strongly on the percentage of prolines and these hydroxyprolines
(Table 1.1).
When the temperature rises at T melt , the viscosity drops and altering optical
rotation properties can be observed. This is caused by the thermal movements, which
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become larger than the cooperative interaction that stabilizes the triple-helix of collagen.
In this way T m is a measure for the stability of the helix structure of a particular collagen.
Table 1.1 Stability of Collagen Helix

Sample
Cod skin *
Frog skin *
Shark skin *
Calf skin *
(Gly-Pro-Pro)n **
Gly-Pro-Hyp)n **
**

Pro+Hyp
155/1000
174/1000
191/1000
232/1000
333/1000
333/1000

Tm(°C)
16
25
29
39
24
58

Body Temperature(°C)
10-14
?
24-28
37
-

Data taken from [10]
Data taken from [11]

From Table 1.1 it might be concluded that the percentage of prolines and
especially the contents of hydroxyprolines positively affects the stability.
The 5-hydroxylysines are covalently bonded to oligosaccharides, mostly
disaccharides of glucose and galactose. In nascent collagen, before it become helical, the
sugars are bonded to the hydroxyl group of hydroxylysines. This occurs with help of the
enzymes galactosyl transferase and glucosyl transferase. The number of sugar residues
and the kind of sugar residues depends on the tissue, but in general fibrils contain
relatively small amounts of sugars while sheets are relatively rich in it. For example, the
fibrillar tendon has only six sugar residues per collagen monomer, while the lenscapsule
has 110 sugar residues. Hydroxylysines are also enormous important for extensive
crosslinking of collagen molecules after secretion of the polypeptides in the extracellular
space.
There are 3.3 amino acid residues per turn and 2.9A per amino acid residue. In a
normal a-helix this is 1.5A per amino acid residue. After self-assemblance of the loose
monomers, cross-links generate the tight, covalently bond complex.
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The amino acid sequence is not totally unique to collagen. If the collagen
sequence is compared with other proteins, homology is found for:
a. C1q subcomponent (chain A, B and C) from the complement system.
b. Acetylcholinesterase.
c. Fibronectin.
d. Osteonectin.
These proteins contain similar stretches of (Gly-X-Y)n [5]. It is expected that
these different proteins somehow interact with collagen to anchor (a and b) or to form
tight complexes (c and d). In this way specific cells can use collagen as a kind of anchor
field with help of specific antibodies.
In all multicellular organisms, many different kinds of tissue can be identified.
Most of these tissues need distinct collagen structures, all with their own specific
properties. For this purpose organisms have genetically distinct collagen a-chains. These
a-chains have been well defined as distinct gene products in higher animals and they are
encoded by many distinct collagen genes [6].
Although from combinatorial point of view, more than a thousand different types
of triple helices can be assembled from the various combinations of the a-chains, only a
few types of collagen have been described and characterized so far.
To obtain the diversity of collagens needed in all different tissues, the distinct
collagen types are modified by some external factors;
a. glycosylation in the endoplasmatic reticulum,
b. post-translational modifications.
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These are mechanisms of introducing a greater degree of variability. Owing to
these modifications, many tissue- specific collagens can be built from one and the same
collagen type [8,14]. The glycosylation takes place intracellular and the posttranslational modifications take place extracellular. Both modifications lead to the finetuning of the collagen structures.
Adaptability to local environment: It has been shown [25] that specific proteoglycans
influence significantly the diameter of collagen fibres. The presence of small
proteoglycans results in collagen fibrils that was significantly thinner in width.
The collagen fibrils in various tissues are organized in ways that largely reflect
the functions of the tissues (Table 1.2)[14].
Table 1.2 The Arrangement of Collagen Fibrils in Various Tissues
Tissue
Tendon
Skin
Cartilage
Cornea

Arrangement
Parallel bundles
Sheets of fibrils layered at many angles
No distinct arrangement
Planar sheets stacked crossways so as to minimize light scatter

1.3 Collagen Biosynthesis
The individual collagen polypeptide chains are synthesized on membrane-bound
ribosomes and injected into the lumen of the endoplasmic reticulum (ER) as larger
precursors, called pro- a chains. These precursors not only have the short amino-terminal
signal peptide required to direct the nascent polypeptide to the ER, they also have
additional amino acids, called propeptides, at both their amino- and carboxyl-terminal
ends. In the lumen of the ER, selected proline and lysine residues are hydroxylated to
form hydroxyproline and hydroxylysine, respectively, and some of the hydroxylysine
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residues are glycosylated. Each pro- a chain then combines with two others to form a
hydrogen-bonded, triple-stranded helical molecule known as procollagen.
Hydroxylysines and hydroxyprolines (Figure 1.3a) are infrequently found in other
animal proteins, although hydroxyproline is abundant in some proteins found in the plant

Figure 1.3a Hydroxylysine and Hydroxyproline.
These modified amino acids are common in collagen; they are formed by enzymes that act after the lysine
and proline are incorporated into procollagen molecules.

cell wall. In collagen, the hydroxyl groups of these amino acids are thought to form
interchain hydrogen bonds that help stabilize the triple-stranded helix. Conditions that
prevent proline hydroxylation, such as a deficiency of ascorbic acid (vitamin C), have
serious consequences. In scurvy, the disease caused by a dietary deficiency of vitamin C
that was common in sailors until the nineteenth century, the defective pro- a chains that
are synthesized fail to form a stable triple helix and is immediately degraded within the
cell. Consequently, with the gradual loss of the preexisting normal collagen in the matrix,
blood vessels become extremely fragile and teeth become loose in their sockets. This
implies that in these particular tissues degradation and replacement of collagen is
relatively rapid. In many other adult tissues, however, the turnover of collagen (and other
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extracellular matrix macromolecules) is thought to be very slow: in bone, to take an
extreme example, collagen molecules persist for about 10 years before they are degraded
and replaced. By contrast, most cellular proteins have half-lives of hours or days.
After secretion, the propeptides of the fibrillar procollagen molecules are removed
by specific proteolytic enzymes outside the cell. This converts the procollagen molecules
to collagen molecules, which assemble in the extracellular space to form much larger
collagen fibrils. The propeptides have at least two functions: (1) they guide the
intracellular formation of the triple-stranded collagen molecules, and (2) because they are
removed only after secretion, they prevent the intracellular formation of large collagen
fibrils, which could be catastrophic for the cell.
The process of fibril formation is driven, in part, by the tendency of the collagen
molecules, which are more than thousandfold less soluble than procollagen molecules, to
self-assemble. The fibrils begin to form close to the cell surface, often in deep infoldings
of the plasma membrane formed by the tandem fusion of secretory vesicles with the cell
surface. The underlying cortical cytoskeleton can therefore influence the sites, rates, and
orientation of fibril assembly.
When viewed in an electron microscope, collagen fibrils have characteristic crossstriations every 67 nm, reflecting the regularly staggered packing of the individual
collagen molecules in the fibril. After the fibrils form in the extracellular space, they are
greatly strengthened by the formation of covalent cross-links between lysine residues of
the constituent collagen molecules (Figure 1.3b). The types of covalent bonds involved
are found only in collagen and elastin. If cross-linking is inhibited, the tensile strength of
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Figure 1.3b Cross-links Formed Between Modified Lysine Side Chains Within a
Collagen Fibril.
The cross-links are formed in several steps. First, certain lysines and hydroxylysines are deaminated by the
extracellular enzyme lysyl oxidase to yield highly reactive aldehyde groups. The aldehydes then react
spontaneously to form covalent bonds with each other or with other lysine or hydroxylysine residues. Most
of the cross-links form between the short nonhelical segments at each end of the collagen molecules.
the fibrils is drastically reduced; collagenous tissues become fragile, and structures such
as skin, tendons, and blood vessels tend to tear. The extent and type of cross-linking
varies from tissue to tissue: collagen is especially highly cross-linked in the Achilles
tendon, for example, where tensile strength is crucial.
Figure 1.3c summarizes the various steps in the synthesis and assembly of
collagen fibrils. Given the large number of enzymatic steps involved in forming a
collagen fibril, it is not surprising that there are many human genetic diseases that affect
fibril formation. Mutations affecting type I collagen cause osteogenesis imperfecta,
characterized by weak bones that easily fracture. Mutations affecting type II collagen
cause chondrodysplasias, characterized by abnormal cartilage, which leads to bone and
joint deformities. Mutations affecting type III collagen cause Ehlers-Danlos syndrome,
characterized by fragile skin and blood vessels and hypermobile joints.

Figure 1.3c The Intracellular and Extracellular Events Involved in the Formation of a
Collagen Fibril.
Note that collagen fibrils are shown assembling in the extracellular space contained within a large infolding
in the plasma membrane. As one example of how the collagen fibrils can form ordered arrays in the
extracellular space, they are shown further assembling into large collagen fibers, which are visible in the
light microscope. The covalent cross-links that stabilize the extracellular assemblies are not shown.
In contrast to GAGs, which resist compressive forces, collagen fibrils form
structures that resist tensile forces. The fibrils have various diameters and are organized
in different ways in different tissues. In mammalian skin, for example, they are woven in
a wickerwork pattern so that they resist tensile stress in multiple directions. In tendons
they are organized in parallel bundles aligned along the major axis of tension. In mature
bone and in the cornea, they are arranged in orderly plywoodlike layers, with the fibrils in
each layer lying parallel to one another but nearly at right angles to the fibrils in the
layers on either side. The same arrangement occurs in tadpole skin (Figure 1.3d).
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Figure 1.3d Collagen Fibrils in the Tadpole Skin.
This electron micrograph shows the plywood like arrangement of the fibrils. Successive layers of fibrils are
laid down nearly at right angles to each other. This organization is also found in mature bone and in the
cornea. (Courtesy of Jerome Gross.).
The connective tissue cells themselves must determine the size and arrangement
of the collagen fibrils. The cells can express one or more of the genes for the different
types of fibrillar procollagen molecules. But even fibrils composed of the same mixture
of fibrillar collagen molecules have different arrangements in different tissues. How is
this achieved? Part of the answer is that cells can regulate the disposition of the collagen
molecules after secretion by guiding collagen fibril formation in close association with
the plasma membrane (see Figure 1.3b). In addition, as the spatial organization of
collagen fibrils at least partly reflects their interactions with other molecules in the
matrix, cells can influence this organization by secreting, along with their fibrillar
collagens, different kinds and amounts of other matrix macromolecules.
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The fibril-associated collagens, such as type IX and XII collagen molecules are
thought to be especially important in this regard. They differ from the fibrillar collagens
in several ways.
(1) Their triple-stranded helical structure is interrupted by one or two short nonhelical
domains, which makes the molecules more flexible than fibrillar collagen molecules.
(2) They are not cleaved after secretion and therefore retain their propeptides.
(3) They do not aggregate with one another to form fibrils in the extracellular space.
Instead, they bind in a periodic manner to the surface of fibrils formed by the fibrillar
collagens: type IX molecules bind to type-II-collagen-containing fibrils in cartilage, the
cornea, and the vitreous of the eye, whereas type XII molecules bind to type-I-collagencontaining fibers in tendons and various other tissues.
Fibril-associated collagens are thought to mediate interactions of collagen fibrils with
one another and with other matrix macromolecules. In this way they play a part in
determining the organization of the fibrils in the matrix [9].

1.4 Types of Collagen
For simplicity, the superfamily of collagens can be divided into several classes on the
basis of the polymeric structures they form or related structural features: (1) collagens
that form fibrils (types I, II, III, V, and XI), (b) collagens that form network-like
structures (the type IV family, and types VIII and X), (c) collagens that are found on the
surface of collagen fibrils and are known as fibril-associated collagens with interrupted
triple helices (FACITs that include types IX, XII, XIV, XVI, and XIX), (d) the collagen
that forms beaded filaments (type VI), (e) the collagen that forms anchoring fibrils for
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basement membranes (type VII), (f) collagens with a transmembrane domain (types XIII
and XVII), and (g) the newly discovered types XV and XVIII collagens that have been
only partially characterized.
(a) Fibril-Forming Collagens: All these collagens (types I-III, V, & XI) are similar in
size and in that they contain large triple-helical domains with about 1000 amino acids or
330 -Gly-X-Y- repeats per chain. In addition, they are also first synthesized as large
precursors, and the precursors need to be processed to collagens by cleavage of Npropeptides and C-propetides by specific proteinases. Finally they are similar in that they
all assemble into cross-striated fibrils in which each molecule is displaced about onequarter of its length relative to its nearest neighbor along the axis of the fibril. Type I is
the most abundant collagen and is found in variety of tissues. Many of the other fibrilforming collagens have a more selective tissue distribution (Table 1.3)
(b) Network-Forming Collagens: These collagens include the family of type IV
collagens found in basement membranes and type VIII and X collagens. The collagenous
domain of a type IV collagen molecule is longer than in the fibril-forming collagens and
consists of about 1400 amino acids in —Gly-X-Y- repeats that are frequently interrupted
by short noncollagenous sequences. Collagen types VIII and X are very different in
structure from type IV but similar to each other. The a 1 (VIII), α2VIII) and a 1(X) chains
all contain a collagenous sequence of almost the same size.
(c) FACIT Collagens: These collagens (types IX, XII, XIV, XVI, and XIX) do not form
fibrils themselves but are found attached to the surfaces of preexisting fibrils of the fibrilforming collagens. All these collagens are characterized by short triple-helical domains
interrupted by short noncollagenous sequences. The type IX collagen molecule consists

17
Table 1.3 Collagen Types and the Location of Their Genes on Human Chromosomes
Type

Gene

Chromosome

Expression

I

COL1A1

17q21.3-q22

Most connective tissues

COL1A2

7q21.3-q22

II

COL2A1

12q13-q14

Cartilage, vitreous humor

III

COL3A1

2q24.3-q31

Extensible connective tissues, e.g. skin, lung, vascular system

IV

COL4A1

13q34

Basement membranes

COL4A2

13q34

COL4A3

2q35-q37

COL4A4

2q35-q37

COL4A5

Xq22

COL4A6

Xq22

COL5A1

9q34.2-q34.3

COL5A2

2q24.3-q31

V

Tissues containing collagen I, quantitatively minor component

COL5A3
VI

Most connective tissues

COL6A1

21q22.3

COL6A2

21q22.3

COL6A3

2q37

VII

COL7A1

3p21

Anchoring fibrils

VIII

COL8A1

3q12-q13.1

Many tissues, especially endothelium

COL8A2

1p32.3-p34.3

COL9A1

6q12-q14

COL9A2

1p32

IX

Tissues containing collagen II

COL9A3
X

COL10A 1

6q21-q22

Hypertrophic cartilage

XI

COL1 1A1

1p21

Tissues containing collagen II

COL11A2

6p21.2

COL2A1 *

12q13-q14

XII

COL12A1

6

Tissues containing collagen I

XIII

COL13A1

10q22

Many tissues

XIV

COL14A1

XV

COL15A1

9q21-22

Many tissues

XVI

COL16A1

1p34-35

Many tissues

XVII

COL17A1

10q24.3

Skin hermidesmosomes

XVIII

COL18A1

21q22.3

Many tissues, especially liver and kidney

XIX

COL19A1

6q12-q14

Rhabdomyosarcoma cells

Tissues containing collagen I

* The α3(XI) chain of type XI collagen is encoded by the same gene as the al (II) chain of type II.
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of three triple-helical domains and four noncollagenous domains. Type XII and XIV
collagens show several structural similarities to type IX collagen, particularly in the Cterminal collagenous domains.

(d) Beaded Filament-Forming Collagens: The only collagen known to form beaded
filament is type VI. Each of the three different chains of the protein contains a very short
triple-helical domain and the remainder consists of large N-terminal and C-terminal
globular domains.

(e) Collagen of Anchoring Fibrils: Type VII collagen forms anchoring fibrils that link
basement membranes to anchoring plaques of type IV collagen and laminin in the
underlying extracellular matrix. The triple-helical domain of type VII collagen, which is
longer than the triple helix of any other collagen, contains 1530 amino acids in —Gly-XY- repeats that are interrupted at 19 separate sites.

(f) Collagens with a Transmembrane Domain: This family of collagens, Type XIII and
Type XVII, contain a transmembrane domain. They are not homologous in structure, but
they both contain a single transmembrane N-terminal domain that is apparently
cytoplasmic.

CHAPTER 2
APPLICATION OF COLLAGEN TUBES

2.1 Collagen as a Biomaterial
Biomaterials is a term used to indicate materials that constitute parts of medical implants,
extracorporeal devices, and disposables that have been utilized in medicine, surgery,
dentistry, and veterinary medicine as well as in every aspect of patient health care. The
National Institutes of Health Consensus Development Conference defined a biomaterial
as " any substance (other than a drug) or combination of substances, synthetic or natural
in origin, which can be used for any period of time, as a whole or as a part of a system
which treats, augments, or replaces any tissue, organ, or function of the body" (Boretos
and Eden, 1984) [2]. A complementary definition essential for understanding the goal of
biomaterials science, is that of "biocompatibility." Biocompatibility is defined as the
"ability of a material to perform with an appropriate host response in a specific
application" (Williams, 1987). The definition applies for the lifetime of the implant,
therefore if an implant is to be placed permanently into the body, it must never illicit a
harmful response. Likewise, a degradable implant must not elicit a harmful response
during its time of operation or after it has degraded into byproducts.
Natural polymers offer the advantage of being very similar, often identical, to
macromolecular substances which the biological environment is prepared to recognize.
The problems of toxicity and stimulation of a chronic inflammatory reaction, which are
frequently provoked by many synthetic polymers, may thereby be suppressed.
Furthermore, the similarity to naturally occurring substances introduces the interesting
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capability of designing biomaterials which function biologically at the molecular, rather
than the macroscopic, level. On the other hand, natural polymers are quite immunogenic.
Furthermore, because they are structurally much more complex than most synthetic
polymers, their technological manipulation is much more elaborate. On balance, these
opposing factors have conspired to lead to a substantial number of biomaterials
applications in which naturally occurring polymers, or their chemically modified
versions, have provided unprecedented solutions. Table 2.1 shows some natural polymers
and their general properties [13].
Table 2.1 Natural Polymer Examples and Functions in Host Animal
Polymer
Silk
Keratin
Collagen
Gelatin
Fibrinogen
Elastin
Actin
Myosin

Incidence
Synthesized by arthropods
Hair
Connective tissue
Partly amorphous collagen
Blood
Neck ligament
Muscle
Muscle

Physiological Function
Protective cocoon
Thermal insulation
Mechanical support
(Industrial Product)
Blood clotting
Mechanical support
Contraction, Motility
Contraction, Motility

The properties of collagen making it suitable for fabrication into medical products
are intimately dependent on characteristics of amino acid composition and sequence
which determine the three-dimensional structure and interaction among other
macromolecules in the environment. As the chief structural protein of the body, collagen
is uniquely designed to transmit tensile and compressive forces of great magnitude [12].
Collagen substrates are known to influence the growth characteristics of cells and also to
modulate various aspects of cell behavior like cell-adhesion, proliferation and
differentiation [15,16,17]. Furthermore, its presence as a constituent of basement
membranes in extracellular spaces suggests that it also contributes in the body and may
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be of some importance in diffusion. The filtration properties of collagen membranes can
have important applications in medicine. The properties of collagen which makes it such
a promising substance for use in the biomedical field are summarized in Table 2.2 [12].
Table 2.2 Factors Favoring the Use of Collagen as Biomaterial

1. Physical-mechanical

2. Physical-chemical

3. Biological

High tensile strength
Low extensibility
Orientation of fibers
Controllable cross-linking by tanning agents;
affects solubility, swelling, resorption
Ion-exchanger function
Semipermeability of membranes
Low antigenicity
Effect on wound healing
Effect on blood coagulation

Certain application of collagen-based biomaterials are shown in Table 2.3
Table 2.3 Certain Applications of Collagen-based Biomaterials
Application
Sutures
Hemostatic agents

Blood vessels
Heart valves
Tendon, ligaments
Burn treatment (Dermal
regeneration)
Peripheral nerve
regeneration
Meniscus regeneration
Intradermal augmentation
Gynecological applications
Drug-delivery systems

Physical state
Extruded tape (Schmitt, 1985)
Powder, sponge, fleece (stengel et al., 1974; Chavapil,
1979)
Extruded collagen tube, processed human or animal
blood vessel (Nimni, 1988)
Processed porcine heart valve (Nimni, 1988)
Processed tendon (Piez, 1985)
Porous collagen-glycosaminoglycan (GAG) polymer
(Yannas et al., 1981, 1982 and 1989)
Porous collagen-GAG copolymer (Chang and Yannas,
1992)
Porous collagen-GAG copolymer (Stone et al., 1989)
Injectable suspension of collagen particles (Piez, 1985)
Sponges (Chvapil, 1979)
Various forms (Stenzel et al., 1974; Chvapil, 1979)
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2.1.1 Collagen Thrombogenicity

Collagen is highly thrombogenic, as is demonstrated from its use as a hemostatic powder
or sponge [18]. Collagen induces platelet adhesion and aggregation as well as activation
of the intrinsic coagulation cascade. Fibrillar collagen preparations are used as
aggregation agent in diagnostic platelet function tests. Where contact of blood with an
injured vessel wall result in extrinsic blood coagulation, contact of blood with purified
collagen induces activation of the intrinsic pathway, initiated by adsorption of (activated)
factor XII [19]. It has been postulated that crosslinking of collagen may decrease its
thromobogenicity [20]. Crosslinking can be done by using different crosslinking agents.
Two procedures of crosslinking will be discussed later in this chapter.

2.1.2 Collagen Antigenicity

It has been suggested that the presence of aromatic amino acids, particularly tyrosine, in
proteins is responsible for a major portion of antigenicity (Sela and Amon, 1960).
Collagen has a low content of aromatic amino acids, and has only approximately three
residues of tyrosine per a-chain. Thus one might expect it to be a weak antigen. It is well
known that the N-terminal regions of the collagenous polypeptide chains which contain
the tyrosine residues are split off by treating tropocollagen with various proteases
(pronase); thus the antigenicity of the collagen sample is reduced (Davidson et al., 1967)
[12].
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2.2 Application of Collagen as Vascular Grafts

Replacing narrowed or occluded portions of larger arteries is becoming a fairly common
medical procedure. Currently, the best vascular graft performance is given by autografts
(tissues taken form one site on a patient and transplanted to another site on the same
patient). Many patient, however, especially those with pre-existing vascular disease or
patients that have already had autograft procedures, do not have blood vessels that are
healthy enough to adequately serve as replacements. The main mechanisms of vascular
autograft failure are thrombosis, emboli production, poor long term patency and intimal
hyperplasia [2]. Failure of the autograft is usually due to some form of occlusion that
results from lumenal narrowing. Damage of the vessel during removal and
reimplementation may cause the recruitment of factors or cells that adhere to the
autograft wall and decrease the diameter or the lumen. The restricted flow then increases
the thrombogenicity, making full occlusion ever more likely. Other problems are
preparation and preservation of the autograft, procedures that can result in vessel damage
or diminished in vivo performance. Finally, due to increased and/or different mechanical
forces, endothelial cells can shrink, diminishing barrier performance and degrade, also
resulting in increased thrombogenicity [21].
Synthetic vascular grafts are made from expanded polytetrafluoroethylene
(ePTFE), Knitted polyethylene terephthalate (Dacron) or polyester. Although grafts made
from synthetic biomaterials perform well when used to replace larger blood vessels, they
are inadequate for replacing small diameter (<6 mm) vessels [3]. In large diameter
synthetic vascular grafts the accumulation of fibrous and cellular material is not great
enough to cause the graft to shrink in diameter significantly. On the other hand, in small
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diameter synthetic vascular grafts the accumulation of material is often significant
enough to cause the blood vessel to become occluded. In order to reduce thrombus
formation anticoagulation drugs are necessary. The use of these drugs often results in
undesirable systemic side effects and can be very problematic. Therefore synthetic
materials are poor choices for materials for small diameter vascular grafts [21].
In cases where the graft can be of a large diameter (> 5-6 mm), the synthetic
material has been effective. However, in situations where a smaller vessel diameter is
required, the synthetic materials cannot be used due to high rates of stenosis and
thrombus formation. One possible solution is to use natural materials like collagen, either
modified or combined with a synthetic material, to form a graft that more closely mimics
the body's natural function and has low thrombogenicity and low incidence of stenosis
[22].
The use of collagen as a material for a synthetic vascular graft is quite promising
because it is biodegradable, antigenic and has good mechanical, haemostatic and cellbinding properties [1,2]. Since collagen is biodegradable, as the device degrades tissue
can grow into the device. This is advantageous because ideally as the collagen implant
degrades the newly formed tissue will replace it, which results in a gradual transfer of
stress from the implanted device to the newly formed tissue. Collagen can be crosslinked
to form a polymer with sufficient mechanical strength to resist the collapse of the blood
vessel.
Heparin is a negatively charged anti-thrombogenic protein that can be
incorporated into collagen, which is inherently thrombogenic. The incorporation of
heparin significantly reduces the thrombogenic properties of collagen and allows it to be
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used as a material for vascular implants. If a collagen vascular implant material were
seeded with endothelial cells so that they coat the lumen, the surface would theoretically
be more biocompatible. Recently, endothelial cells have been cultured onto the collagen
small diameter vascular grafts. The growth of endothelial cells into the collagen vascular
graft can be increased by incorporating growth factors into the vascular graft material.
Basic fibroblast growth factor (bFGF) can be immobilized by the heparin that is already
incorporated into the collagen that is used for a vascular implant. bFGF caused more
tissue to grow into the implant material and helped form a coating of endothelial cells on
top of the implant material. Therefore by incorporating bFGF into the collagen vascular
implant material endothelial cells can be seeded onto the top of the material to create a
lumenal surface that is comprised of endothelial cells to more closely mimic the natural
biological environment [23].
To reduce the antigenicity, as discussed before, collagen should be crosslinked
with different method. Crosslinking of collagen will also enhance mechanical strength
and time needed for degradation of collagen tubes. Many crosslinking methods can be
used i.e. chemical cross-linkage using formaldehyde, hexamethylene diisocyanate,
glutaraldehyde (GA) or N-(3-dimethyaminopropyl)-N'-ethylcarbodiimide (EDC) and Nhydroxysuccinimide (NHS), physical cross-linking using irradiation, ultraviolet(UV)
irradiation or heat treatments.
Depending on the intended application, the ability for natural polymers to be
broken down by enzymes allows for the complete degradation of an implanted material.
This can be an advantage if the implant is only meant for short-term usage and eventual
replacement by the body's own materials. For collagen, the cells can synthesize new
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collagen, which normally forms a new architectural arrangement, such as scar tissue, in
wounds. This is one step in the wound healing process that the body begins as a result of
damage caused by implantation.
This degradation can also be a disadvantage if these enzymes destroy the implant
before it completes its intended task. Collagen is susceptible to attack by collagenases in
a physiological setting. These collagenases are present in healing wounds and are a
primary reason for the degradation of collagen implants. Luckily, through various
physical or chemical methods, the degradation rate of collagen implants can be controlled
[24].

2.3 Physical Modification of Collagen
The porosity of collagenous implants normally makes an indispensable contribution to its
performance. A porous structure provides an implant with two critical functions. First,
pore channels are ports of entry for cells migrating from adjacent tissues into the bulk of
the implant or for the capillary section of blood from a hemorrhaging blood vessel
nearby. Second, pores endow a solid with a frequently enormous specific surface which
is made available either for specific interactions with invading cells or for interaction
with coagulation factors in blood flowing into the device (e.g. hemostatic sponges) [13].
Porosity is significant because it controls the tendency to hemorrhage during and
after implantation and controls the ingrowth of tissue into the wall of the graft. It is
desirable that the vascular graft substrate be sufficiently blood-tight to prevent the loss of
blood during implant, yet the structure must be sufficiently porous to permit ingrowth of
fibroblast and smooth muscle cells in order to attach the graft to the host tissue. Grafts
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which are impermeable to blood after the time of implantation do not permit the
subsequent ingrowth of cells which is necessary for uniform and satisfactory bonding of
the internal lining of the prosthesis. The general procedure for implantation includes the
step of pre-clotting, wherein the graft is immersed in the blood of the patient and allowed
to stand for a period of time sufficient for clotting to insue. After pre-clotting,
hemorrhaging does not occur when the graft is implanted and growth of tissue is not
impeded [26].
Cross-linking of collagen biomaterials is often applied to control or reduce the in
vivo resorption rate or to improve mechanical properties of materials [27,28]. In general,
there are two methods for crosslinking of collagen: physical and chemical.
The most common physical method is dehydrothermal treatment. By heating in an
oven, collagen can be severely dehydrated which creates interchain amide links. By
exposure to temperature in excess of 105° C with atmospheric pressure for a few hours,
the collagen can produce cross-links which help to prevent degradation of the helix. The
ultimate tensile strength may be improved by preventing interfibrillar slippage and also
removing the water molecules which swell the matrix and prevent hydrogen and other
forms of electrostatic bonding between the collagen. Dehydrothermal treatment of
collagen requires a careful balance between the amount of time exposed to heat to
provide adequate cross-links and the amount of time which could lead to the denaturing
or degrading of the tissue.
Another less widely used method for cross-linking collagen is through exposure
to short wave ultraviolet irradiation of gamma radiation. An issue with this however, is in
determining how deep the radiation will penetrate and subsequently how many cross-
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links it will produce. Although these methods do not introduce potentially harmful
chemical to the collagen, they are not as effective as chemical treatments which have
been used commercially for years and, as previously stated, can help lower antigenicity
while increasing the tensile strength of the collagen.

2.4 Chemical Modification of Collagen
Collagen-based implants are normally degraded by collagenases, naturally occurring
enzymes which attack the triple helical molecule at a specific location. An effective
method for reducing the degradation rate of collagen by naturally occurring enzymes is
chemical cross-linking.
Reagents like glutaraldehyde, formaldehyde and diisocyanates introduce
crosslinks between two c-amino groups of lysine and/or hydroxylysine residues of
reconstituted collagen. Secondly, crosslinking can be carried out by introducing amide
bonds between carboxylic acid groups from aspartic or glutamic acid residues and εamino groups. Examples are cyanamide crosslinking, acyl crosslinking and the use of
carbodiimide [29].
Several studies have been directed towards the use of novel epoxy compounds for
cross-linking of collagen. It has been demonstrated that, depending on pH, bis-epoxy
compounds introduce crosslinks between either carboxylic acid groups, or primary amino
groups of collagen [28].
Crosslinking of collagen in commercial collagen-coated synthetic vascular grafts
is commonly carried out using glutaraldehyde or formaldehyde. The mechanism of
crosslinking by these reagents is complex and poorly understood. Using glutaraldehyde it
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is assumed that Schiff base intermediates are formed by reaction of aldehyde groups of
glutaraldehyde with amino groups of collagen (I). Subsequent reactions of these
intermediates results in the formation of large variety of possible crosslink-moieties [30].
Figure 2.1 shows the mechanism of crosslinking with glutaraldehyde.

Figure 2.1 Mechanism of Crosslinking with Glutaraldehyde.
The use of glutaraldehyde has an important drawback as it is incorporated in
collagen material. Glutaraldehyde is known to induce local cytotoxicity by the release of
(unreacted) crosslink-agents or derivatives thereof, during both in vitro and in vivo
application of collagen biomaterials [31]. It has been shown that residual glutaraldehyde
completely inhibits in vitro fibroblast proliferation at concentrations as low as 3 ppm
[32]. It can be concluded that upon implantation, cytotoxic reactions hamper
endothelialization of currently available collagen coated synthetic vascular graft
materials. In addition, glutaraldehyde crosslinking of collagen- based biomaterials is
associated with enhanced calcification of the implant, which has an adverse effect on the
mechanical properties of material [33].
Crosslinking of collagen using N-(3-dimethyaminopropyl)-N'-ethylcarbodiimide
(EDC) and N-hydroxysuccinimide (NHS) is based on a well known method in peptide
synthesis. The reaction of EDC with carboxylic acid groups of collagen results in the
formation of 0-acylisourea. When 0-acylisourea reacts with NHS reactive NHS-esters
are formed [34], and release of water-soluble 1-ethyl-3(3-aminopropyl)urea (EDU)
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occurs. Subsequently, reaction of NHS-esters with free ε-amino groups of
(hydroxy)lysine residues results in the formation of peptide crosslinks and liberated NHS.
Direct reaction of 0-acylisourea with free ε-amino groups also results in formation of
peptide crosslinks. NHS, however, prevents side reactions of 0-acylisourea groups like
hydrolysis and N-acyl shift to the stable N-acylisourea. Figure 2.2 shows the mechanism
of crosslinking with EDC/NHS.

Figure 2.2 Mechanism of Crosslinking with EDC/NHS.
The EDC/NHS crosslinked collagen is reported to be non-cytotoxic in vitro, and
biocompatibility was demonstrated in animal models [35]. When subcuteneously
implanted in rates, calcification of EDC/NHS crosslinked collagen proved to be very low
compared to glutaraldehyde crosslinked collagen [36].

CHAPTER 3
MATERIALS AND EXPERIMENTAL METHODS

3.1 Collagen Extraction Process
The process to extract collagen from bovine tendon is developed with the help of Mr.
Nels Lauritzen and Dr. Joseph Nichols of Prodex Science Inc., located in Princeton, New
Jersey, USA. The process uses bovine superficial flexor and deep flexor tendons as
collagen source.
Approximately 1000 grams of frozen bovine tendon was sliced using the NBI
Nantsune deli slicer. The sliced tendon was ground using electric meat grinder (w/4.5
mm grinder plate). To determine the % solid weight in the ground tendon, small sample
of the wet tendon was weighed and then dried it in a oven for 4 hr to overnight at 100 °C
to determine the dry weight. The % solid was calculated by using the value of wet
weight and dry weight.
The 8.4 liters of KH 2 PO 4 (Potassium Phosphate Monobasic) solution was
prepared by adding 41.25 grams of KH 2 PO 4 to 8.4 liters of distilled or demineralized
water. Then 1.77 grams of NaOH was added to solution to get the pH of 6.15 ± 0.15. The
weighed out ground tendon was added to above solution. The mix was then warmed up to
37 °C using hot plate. Then 300 ml of previously prepared buffer solution was taken and
10 grams of Ficin was dissolved in it. Immediately 300 ml of ficin premix was added in
the buffer solution and noted the enzyme activity. The solution was stirred intermittently
and kept it at 37 ° C ± 2 for 1 hour.
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Enzyme deactivation solution was prepared by adding 84 gms of NH 4 NO 3 and 10
grams of NaClO2 in 8.4 liters of distilled water. Wearing latex gloves, the enzyme treated
fiber was strained and hand squeezed to remove excess water and placed into the enzyme
deactivation solution. A perforated funnel (colander) was used to obtain last bits of fibers.
The fibers were kept in this solution for 1 hour with intermittent stirring. After that
wearing latex gloves, once again fibers were strained and hand squeezed to prepare for
washing. Then fibers were washed 3 times for 15 minutes using 3 liters of distilled water.
For alkalai treatment, a solution was prepared by adding 1400 gms of anhydrous
sodium sulfate and 350 gms of NaOH to 6.8 liters of distilled water. The temperature was
stabilized at 25 ± 1 °C. Fibers were kept in this solution for 42 hours at 25 ± 1 °C. After
42 hours the fibers were washed 3 times with 3 liter sodium sulfate solutions for 15
minutes. Following these washes fibers were once again washed 3 times with 3 liters of
distilled water, adjusted to pH of 4.6 by using dilute H2SO4, for 15 minutes.
For isopropanol (IPA) treatment, fibers were placed into 2-3 liters of 100%
isopropanol at 60 °C slowly and carefully, avoiding the hot spots and potential
degradation. The blend was kept stirring to avoid hot spots. Fibers were kept in this
condition for 2 hours and then prepared for second wash with isopropanol. The second
wash proceeded with harvesting the fibers from the first wash by hand squeezing the
fibers and colander staining to remove excess IPA. The fibers of second wash were
allowed to remain in IPA at 60 ° C for 1 day. After that fibers were teased and placed into
Pyrex dish to dry it in to oven at 45 °C overnight. Dried collagen fibers were stored in
refrigerator.
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3.2 Collagen Suspension Preparation

To prepare the collagen suspension of C %, 10 x C grams of collagen fibers were soaked
in 1000 ml of distilled water. C ml of lactic acid was also added to break down the fibers
in the water. The fibers were allowed to soak in this condition for 10-15 minutes. Then
this mixture was blended for 30 second in laboratory blender followed by allowing it to
set for 15 minutes and loose the heat it received by blending and not letting the
temperature go up. The mixture was blended for 30 seconds followed by 15 minutes
break and last cycle of 30 second blending. At the end of third cycle of blending the
mixture became thick paste. The paste then transferred in bottles and stored in
refrigerator. The collagen suspension was centrifuged for enough time to remove air
bubbles if necessary before using them to extrude tubes.

3.3 Collagen Tubes Extrusion Protocol

The collagen tubes were extruded using a special collagen extrusion machine developed
by ZOKO spol. S r.o. of Czechoslovakia. The extrusion machine used a piston to force
the collagen gel through a rotating mandrel where it was deposited on a guide rod. The
rod itself was lifted away at uniform speed from the mandrel to form an even coating.
The collagen was deposited onto the rod after passing through a rotating head which
oriented the get to the left or the right according to the its rotation in left or right
direction. The rotation head had speeds ranging from 22- 260 rpm in either direction. In
order to adjust the thickness of the tube, the pulling device also had variable speeds
ranging from 152 — 1522 mm/min in the upward or downward direction. The rate of
extrusion was also adjustable by controlling the upward motion of the piston. The
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extrusion rate had the range from 2 — 50 cm 2 / min. The extrusion machine had a cylinder
with a volume of approximately 1925.625 cc. The maximum pressure allowed in the
cylinder head was 3 MPa and was regulated by an electronic meter attached to an oil
reservoir which shut off the extrusion if the pressure exceeded the maximum value. To
allow for chemical treatment of the tubes, homemade baths were made from PVC piping
40 in. long and sealed on both ends with caps adding an additional 1 in. length. These
baths were then cut in half lengthwise to provide adequate length and ease of access.

3.3.1 Protocol for Pre-Extrusion
Two types of rods were used as guide rods for extrusion process, stainless steel and teflon
both 36" in length. Because of good surface properties of teflon, teflon rods didn't need
any pre-extrusion treatment. To facilitate isolation of tube from stainless steel rod, one of
the PVC baths was filled with 99% pure glycerin from Fisher Scientific company of
Somerville, New Jersey. The stainless steel rods were placed into the glycerin bath and
allowed to soak for about 10 minutes to provide a uniform coating to the rods. Then the
guide rods were hung for 1-2 minute to drain off excess glycerin into the bath.
In order to prevent contamination, parts of the extrusion machine that
comes in direct with collagen were disassembled and washed before the start up of new
experiment or batch.
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3.3.2 Protocol for Extrusion

After switching on the machine, letting it warm up, the piston was lowered to its lowest
point and the piston head was manually pushed into place at the bottom of the cylinder.
Cylinder then was filled tightly up to 314 th of its height with collagen dispersion. The
desired extrusion head and nozzle were attached to the machine to ensure that the guide
rod would pass through the nozzle without any interference. The cylinder top was then
covered and a 1 1/2 ft. PVC tube was connected from the cylinder head to the extrusion
head manifold. The swinging arm was lowered close to the extrusion head to clamp the
guide rod. A glycerin coated stainless steel rod was inserted through the bottom of the
nozzle up through the extrusion head and then clamped into the swinging arm. To ensure
continuous extrusion of collagen, the PVC tube was allowed to purge. The machine was
set for the desired extrusion rate, rotation speed, and linear pull speed.
The rotation motor was started as soon as collagen began filling the manifold. The
collagen was continuously filling the manifold and finally became visible around the rod
through the top of the extrusion head. At this point, the linear drawing arm was then
activated and moved at the desired speed. The collagen was now being extruded onto the
rod and a visual check was made to ensure uniform coating of collagen slurry around the
tubes. Once the guide rod had completely entered the manifold, the extrusion and rotation
was stopped to prevent wasting of collagen. The swinging arm was allowed to rise until
the guide rod was completely out of the manifold at which point the arm was opened and
lowered. The rod was removed and hung on the drying racks.
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This process was repeated for each tube of various collagen concentration. After
each trial, the rods were prepared for post-extrusion treatment and the machine was
cleaned.

3.3.3 Post-extrusion Tube Treatment
The main goal of this treatment is to chemically treat the collagen and dry the tubes to
facilitate the easy removal from guide rods. The chemical treatment is composed of two
parts, namely coagulation or reconstitution and cross-linking. The tubes prepared from
the above protocols were treated differently according to the protocols for different
studies. The tubes were extruded according to the protocols written in section 3.3.1 and
3.3.2 and dried according to procedure described as follows.
After drying stainless steel rods for 18 to 24 hours under ambient conditions, the
tubes were deemed dry. The tubes were allowed to soak in the water bath to rehydrate the
tubes. They were kept in the water bath for approximately 1 i/2 hour to allow enough
water to absorb through the entire tube. Then the tubes were immediately cut to the
desired length and slipped off from the stainless steel rods. The rehydration made the
collagen tubes more flexible and with slight twists at small intervals along the tube, the
bond with the rod was loosened enough to pull the cut tubes smoothly without damaging
the tube or causing it to loose its shape. Some of the rods were not completely rehydrated
under the standard time, particularly the thick tubes, so they were returned to the water
bath for an additional 30 minutes until they were easily slipped off from the stainless
steel rods.
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Now the tubes no longer supported by the guide rod, curling would occur with the
final drying without intervention. To prevent this undesirable shape change, the collagen
tubes were placed in drying cardboard boxes. A pair of holes were drilled on the opposite
side wall of specially prepared cardboard boxes. Screws with diameter approximately
same as guide rods were placed in the holes. Two ends of cut tube were then fixed on the
two opposite screws on the box. Tubes were actually cut of the length, so that it can fit on
the screws with slight tension. The tubes were allowed to dry for 18 to 24 hours in this
condition and then removed from the rack and stored in boxes to prevent any damage.

3.4 Glutarldehyde Cross-linking Protocol

Ammonium hydroxide (NH4OH) and glutaraldehyde, the crosslinking agent, used in this
protocol were received from Fisher Scientific as 5% v/v and 25% v/v solution
respectively. NH4OH was diluted to 1% and glutaraldehyde was diluted to 0.6% & 5 %
using distilled water. In order to ensure adequate chemical concentration for all the
tubes, these chemicals were refilled after treating every two tubes with the reminder of
the chemical being removed for disposal.
Three baths each with 1 liter of ammonium hydroxide, 1 liter of glutaraldehyde
and 1 liter of water in it were prepared for treatment of extruded tubes. The extruded
collagen tubes were incubated in ammonium hydroxide solution. The tube was soaked for
10 minutes with occasional agitation and rotation of the rod to ensure good chemical
absorbance. The rod was removed from the bath and washed for 5-7 minutes in a water
bath to remove excess chemicals from the surface.
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After washing, the rods were incubated in glutaraldehyde solution bath and
allowed to soak for 5 minutes with occasional agitation and rotation followed by washing
in a water bath for 5-7 minutes. The rod was subsequently hung on the vertical hanging
rack to allow excess moisture to drip off and the tube dried.

3.5 EDC/NHS Cross-linking Protocol
The cross-linking agents used for this treatment were N-(3-dimethylaminopropyl)-N'ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS). Crosslinking was carried out in a buffer of 2-morpholinoethane sulfonic acid (MES buffer,
0.05 M, pH=7.4 was adjusted using 10 M NaOH) to minimize hydrolysis of EDC. These
chemicals were ordered from Fischer Scientific. Extruded collagen tubes were coagulated
by 1% ammonium hydroxide for 10 minutes followed by washing in water bath for 5
minutes. Washed tubes were hung on drying rack for 15-18 hours to dry. Dried collagen
tubes were incubated in MES buffer for 30 minutes. Subsequently, the tubes were
immersed in a solution of EDC and NHS in MES buffer, and cross-linking was carried
out under gentle shaking.
Typically, crosslinking was carried out using 0.731 g EDC and 0.415 g NHS in
500 ml MES- buffer per gram of collagen (1.29 mmol carboxylic acid groups, CollCOOH, per gram of collagen, resulting in a molar ratio of EDC : NHS : Coll-COOH of
7.0 : 2.8 : 1). Approximately 2.5 feet long tubes were crosslinked so 3.655 gms (0.019M)
of EDC and 2.075 gms (0.018 M) of NHS was dissolved in 500 ml of MES solution.
After 1 hour, crosslinking was stopped by washing the collagen film with 0.1 M sodium
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phosphate dibasic (Na2HPO4) solution for 2 hours. Then the rod was hung on vertical
hanging rack to dry for 15-18 hours under ambient conditions.

3.6 Degradation Study Protocol
The collagenase, Tris-HCl, CaCl2 and EDTA used for this study were ordered from
Sigma Aldrich Co., St. Louis, MO. The solution of 0.05 M CaCl2 and 0.25 M EDTA
were prepared using distilled water. For this study collagen tubes were extruded using
setting of extrusion speed 25 cm 2 /min, linear draw rate 300 mm/min, rotation rate 60
rpm. Two different concentration of collagen suspension were used for this study 2.0%
and 2.5%. Two tubes of each concentration were extruded. All the tubes were
reconstituted by using 1% ammonium hydroxide for 10 minutes followed by washing in
water bath for 5 minutes. One tube of each concentration was cross-linked by using 0.6%
glutaraldehyde for 5 minutes while other two tubes were cross-linked by using EDC/NHS
according to the protocol described in section 3.5. After cross-linking all the tubes were
given water wash for 5-7 minutes and then hung on drying rack for 18-24 hours. After
drying all the tubes were separated from guide rod as explained in section 3.3.3.
Seven samples of each tube, each weighing approximately 25 mg, were prepared
for this study. Initial dry weight of the samples was recorded before the start of study.
Glutaraldehyde and EDC/NHS crosslinked samples were tested for 2 hr, 4 hr, 6 hr, 8 hr,
10 hr, 12 hr and 14 hr.
First the samples were incubated for 1 hr in 5 ml 0.1 M Tris-HCl (pH 7.4),
containing 10 ml 0.05 M CaCl 2 at 37 °C. Separate aluminium pans were used for each
sample and covered with aluminium foil to avoid possible evaporation of solution.
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Subsequently 30 mg 291 U bacterial collagenase (Clostridium histolyticum, EC 3.4.24.3,
Sigma Chemical Co.) was added to above solution. After specified time for each sample,
the reaction was stopped by the addition of 1 ml 0.25 M EDTA and cooling the mixture
on ice. Then samples were dried under atmospheric conditions for 18-24 hours. The final
dry weight of the samples was recorded. The extent of degradation was determined from
the final weight of samples and expressed as percentage weight loss after the collagenase
treatment.

3.7 Porosity Characterization
The Mercury Porosimeter is a versatile and accurate instrument used to determine
properties such as pore size distribution, total pore volume, surface area, and bulk and
absolute densities of solid and powder samples. The Mercury Porosimeter fills the
penetrometer and sample chamber with mercury under vacuum and takes a volume
reading. The sample, however, is not initially intruded with mercury because of the high
surface tension. Gradually, increasing amounts of pressure are applied. For each
incremental increase in pressure, the change in intrusion volume is equal to the volume of
the pores whose diameters fall within an interval that corresponds to the particular
pressure.
The theory of all mercury porosimeters is based on the physical principle that a
non-reactive, non-wetting liquid will not penetrate pores until sufficient pressure is
applied to force its entrance. The relationship between the applied pressure and the pore
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size into which mercury will intrude is given by the Washburn equation:
PD = -47 cos 0
where P is the applied pressure, D is the diameter, 7 is the surface tension of mercury
(480 dyne cm -1 ) and 0 is the contact angle between mercury and the pore wall, usually
near 140°. As pressure increases, the instrument senses the intrusion volume of mercury
by the change in capacitance between the mercury column and a metal sheath
surrounding the stem of the sample cell. As the mercury column shortens, the pressure
and volume data are continuously acquired and displayed by an attached personal
computer.
The concentration of glutaraldehyde used for this study was 5%. The samples
were cut in to 2.7 cm H x 2 cm D dimensions and were prepared for pore volume, pore
size distribution, surface area and porosity characterization. Mercury contact angle (0)
was taken as 140 degrees. The samples were identified as follows:
Table 3.1 Sample Identification for Porosity Characterization
Sample No.
1
2
3
4

Description
2% Collagen, NH4OH coagulation, Glutaraldehyde cross-linked
2% Collagen, NH4OH coagulation, EDC/NHS cross-linked
2.5% Collagen, NH 4 OH coagulation Glutaraldehyde cross-linked
2.5% Collagen, NH4OH coagulation, EDC/NHS cross-linked

CHAPTER 4
RESULTS AND DISCUSSION

The collagen tubes were successfully extruded using collagen extrusion machine.
Stainless steel rods were used for extrusion. Thanks to glycerin coating on guide rods,
tubes were easily isolated from guide rods. Drying was carried out under normal
atmospheric conditions. Extrusion variables had a great effect on wall thickness.
Glutaraldehyde treated tubes turned reddish yellow after drying, while there was no
change in color for EDC/NHS treated tubes. For porosity characterization and
degradation study, different glutaraldehyde concentration (5% & 0.6% respectively) was
used because collagenase had no significant effect on samples crosslinked with 5%
glutaraldehyde for up to 72 hours. The inner diameter of the tubes reduced after drying
due to shrinkage of tubes.

4.1 Results of Degradation Study
Collagen crosslinking using EDC involves the activation of carboxylic groups of
glutamic and aspartic acid residues, and the formation of amine bonds in the presence of
lysine or hydroxylysine residues. The addition of NHS increases the rate and degree of
crosslinking.
The enzymatic degradation of extruded collagen tubes was performed using
collagenase (Clostridium histolyticum, EC 3.4.24.3, Sigma Chemical Co.). The samples
crosslinked with glutaraldehyde and EDC/NHS were evaluated for their enzymatic
stability against collagenase digestion. Non-crosslinked samples almost completely
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degraded after 2 hours. The dry weight before and after the collagenase treatment was
used to calculate the percentage weight loss after the treatment as shown in Table 4.1.
Table 4.1 Results of Degradation Test
Time(hr)

2
4
6
8
10
12
14

% Weight loss
Sample #3

Sample #4

Sample #1

Sample #2

(2% Coll., GTA
Crosslinked)

(2% Coll., EDC/NHS
Crosslinked)

(2.5% Coll., GTA
Crosslinked)

(2.5% Coll., EDC/NHS
Crosslinked)

1.58
2.68
3.87
5.69
7.8
9.49
10.35

0.32
0.75
0.88
1.22
1.48
1.95
2.91

1.84
3.09
4.1
6.86
8.78
9.96
12.49

0.42
1.12
1.59
1.49
1.76
2.26
3.35

The data in Table 4.1 was used to plot percentage weight loss as a function of time
(Figure 4.1 and Figure 4.2).

Figure 4.1 Plot Showing Percentage Weight Losses as a Function of Time for
Glutaraldehyde Treated Tubes.

Figure 4.2 Plot Showing Percentage Weight Losses as a Function of Time for
EDC/NHS Treated Tubes.
Figures 4.1 and 4.2 show the effect of collagenase on glutaraldehyde and
EDC/NHS crosslinked samples as well as collagen concentration. As can be seen from
these plots, the slopes of curves for sample number 1 and 3 are much steeper than those
for sample number 2 and 4. This suggests that percentage weight loss is much higher for
samples crosslinked with glutaraldehyde than the ones crosslinked with EDC/NHS. That
means that EDC/NHS treated tubes degraded slower than glutaraldehyde treated tubes.
Collagenase cleaves a unique site of peptide bonds in triple-helical collagen, i.e. the
primary sequence of the amino acids leucine and glycine [37]. The structural integrity
after chemical crosslinking caused enzymes to have difficulty in reaching attack sites in
collagen, possible due to many intermolecular cross-links [38].
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Furthermore, as can be seen from the plots, it can be concluded that 2.5%
collagen samples showed less resistance to degradation compared to 2% collagen
samples because of the difference in amount of fibers they contain.
Considering simple best linear fit for the curves, predictive equations for the
curves of weight loss vs. time are derived. These predictive equations shows the
degradation rate of collagen tubes inside body and can further be used to design an in
vitro model of these tubes as small diameter vascular grafts.
These predictive eauations are:

Where, y = % weight loss
x = time (hr)
R = correlation coefficient
Since the degradation rate is zero at the start of experiment, there is no weight loss at time
t = 0. Also the point (0, 0) is included in each data set for samples. So the y intercepts in
the above equations can be neglected theoretically. Hence, these equations take the form,

Where OW is percentage weight, t is time in hour and constant k can be taken as 0.82 for
glutaraldehyde treated tubes and 0.19 for EDC/NHS treated tubes. The above equation is
the model equation for degradation rate of collagen tubes which shows the relationship
between the mass degraded and time.
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4.2 Results of Porosity Characterization
The collagen tubes samples were characterized for porosity using mercury porosimeter.
The data recorded were pressure (psia), pore diameter (microns) and cumulative pore
volume (cc/g). Some of the nomenclatures used in the data are explained below:
1. Cumulative pore volume = Pore volume belonging to the pores of diameter > D
2. % Total pore volume = % of total cumulative pore volume belonging to the pores
of diameter > D
3. Average pressure = square root of P(I) * P(I-1)
4. Pore size distribution function = A V/ A log D
Table 4.2 Summary of Porosity Characterization Results
Sample weight (g)
Total intrusion volume (cc/g)
Total surface area (m2 /g)
Median pore dia. (Based on Vol.) (p.)
Median pore dia. (Based on Surf. area)(μ)
Standard deviation (Based on Vol.) (p.)
Standard deviation (Based on Surf. area) (p.)
Average pore dia. (4V/S) (p.)
Dia. of min. value of dV/dlogD

#1
0.2000
0.2179
80.6494
0.0153
0.0052
0.0054
0.0019
0.0108
0.00383

#2
0.0700
0.6559
216.1894
0.0259
0.0053
0.006
0.002
0.0121
0.003683

#3
0.1800
0.2585
92.9195
0.0165
0.0052
0.0056
0.0019
0.0111
0.003620

#4
0.1700
0.4434
110.100
0.062
0.0055
0.0078
0.0023
0.0161
0.00372

Table 4.2 shows some properties of collagen tubes obtained by porosity
characterization.
From the intrusion volume data in Table 4.2, it can be concluded that EDC/NHS
treated samples are more porous than glutaraldehyde treated samples. Also from Table
4.2 and Figure 4.7, EDC/NHS treated samples have more surface area than
glutaraldehyde treated samples.

Figure 4.3 Pore Distribution Histogram for 2% Collagen, GTA Crosslinked Samples.

Figure 4.4 Pore Distribution Histogram for 2% Collagen, EDC/NHS Crosslinked Samples.
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For the application of endothelial cells on vascular grafts, higher surface area is
advantageous, but it might be disadvantageous from the point of view of thrombus
formation. Figures from 4.3 to 4.6 represent pore distribution for each kind of sample.

Figure 4.5 Pore Distribution Histogram for 2.5% Collagen, GTA Crosslinked Samples.

Figure 4.6 Pore Distribution Histogram for 2.5% Collagen, EDC/NHS Crosslinked Samples

Figure 4.7 Cumulative Surface Area of Samples.

CHAPTER 5
CONCLUSION

One effect of crosslinking is increased resistance to enzymatic degradation by bacterial
collagenase. In the present study, enzymatic degradation of non-crosslinked tubes
resulted in a removal of non-fibrillar collagenous substance. Tubes crosslinked with 5%
glutaraldehyde had developed higher resistance against enzymatic degradation. From
degradation study results, it can be inferred that the EDC/NHS treated tubes showed
greater resistance to enzymatic degradation than glutaraldehyde treated tubes. It can also
be concluded that the higher the collagen concentration, the higher the degradation rate.
The predictive equations derived from the data of degradation study can be used to design
an in vitro model for small diameter collagen tubes. The in-vitro model equation for the
degradation rate of small diameter collagen tubes showed linear behavior.
From porosity characterization study, it can be concluded that EDC/NHS treated
samples are more porous than glutaraldehyde treated samples. The EDC/NHS treated
samples have more surface area than glutaraldehyde treated samples. This is
advantageous in cases where endothelial cell seeding is desired.
Also the tubes are not porous enough and do not have optimum surface area to
mimic the natural blood vessel. The amount of thrombus deposition is proportional to the
surface area of the exposed device and may be increased by deposition of fibrinogen into
cracks on the surface [4]. Future work will be to study biodegradation rate for small
diameter collagen tubes over longer period of time. The possible research could be in the
direction to reduce the thrombogenicity and optimize the porosity of EDC/NHS treated
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tubes and to develop a graft with porosity such that it prevents the loss of blood during
implant but permits ingrowth of fibroblast and smooth muscle cells in order to attach the
graft to the host tissue. The reduction in thrombogenicity can be accomplished by coating
the tubes surface with endothelial cells.
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